Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
U.S. Sen. Amy Klobuchar joined Lanon Baccam in Des Moines Friday for a fundraiser and roundtable discussion focused on ...
Before Liam Payne died at age 31 on Oct. 16 after falling multiple stories at the CasaSur Palermo Hotel in Buenos Aires, ...
According to a Shotspotter alert, at least 37 shots were fired just before 11 p.m. near the corner of N. Calhoun and ...
Abby had a 90% chance of beating the blood cancer if she followed a three-year treatment. There was just one problem. Start ...
The musician suffered multiple traumas that led to internal and external bleeding after falling from his hotel room in ...
An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new ...
The report said that one of the handguns had a loaded high-capacity drum magazine and a full-automatic conversion kit, which ...
A Youngstown couple is facing charges after Mahoning County Prosecutors say they tried to have drugs snuck into the jail.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback